govtjobshome
download (4)
Nizam Institute of Medical Sciences (NIMS) has released a notification to fill Study Coordinator posts for the project entitled as ‘Trail No = 1160.186: A Prospective randomized, open label, blinded endpoint (PROBE) study to evaluate DUAL antithrombotic therapy with dabigatran etexilate (110 mg and 150 mg b.i.d) plus clopidogrel or ticagrelor vs. triple therapy strategy with warfarin (INR 2.0 – 3.0) plus clopidogrel or ticagrelor and aspirin in patients with nonvalvular atrial fibrillation (NVAF) that have undergone a percutaneous coronary intervention (PCI) with stenting (RE-DUAL PCI)’ on contract basis. Other details are given below…
download (4)
Nizam Institute of Medical Sciences (NIMS) has released a notification to fill Study Coordinator posts for the project entitled as ‘Trail No = 1160.186: A Prospective randomized, open label, blinded endpoint (PROBE) study to evaluate DUAL antithrombotic therapy with dabigatran etexilate (110 mg and 150 mg b.i.d) plus clopidogrel or ticagrelor vs. triple therapy strategy with warfarin (INR 2.0 – 3.0) plus clopidogrel or ticagrelor and aspirin in patients with nonvalvular atrial fibrillation (NVAF) that have undergone a percutaneous coronary intervention (PCI) with stenting (RE-DUAL PCI)’ on contract basis. Other details are given below…